Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Neuromuscul Disord. 2010 Dec 30;21(3):204–213. doi: 10.1016/j.nmd.2010.12.003

Figure 2. Detection of MG patient autoantibodies by a panel of AChR-α1 truncation mutants.

Figure 2

A cohort of MG patients (N=14) and controls (N=15) was screened for autoantibodies using full length AChR-α1 and 10 deletion mutants. Each point represents the average amount of fusion protein immunoprecipitated in two independent experiments by each patient in LU. The long solid line in each graph represents the cutoff derived from the average plus three standard deviations of the control group.